Table 5.
WHIM Subject Data by Periodontal Diagnosis
WHIM Subjects | Stage I/II | Stage III/IV | p-value |
---|---|---|---|
Age | 25 (21 – 38) | 40 (33.5 – 52.8) | 0.0319 |
Gender (Male/Female) (number) | 3/4 | 5/9 | >0.9999 |
Ethnicity (Caucasian/Non-Caucasian) (number) | 6/1 | 8/6 | 0.3371 |
Hispanic | 1 | 4 | |
Black | 0 | 2 | |
Asian | 0 | 0 | |
Smoking (Former or Current/Never) (number) | 0/7 | 3/11 | 0.5211 |
BMI | 23 (21 – 27) | 26 (20.8 – 29.3) | 0.8411 |
White Blood Count (WBC) | 1200 (960 – 7590) | 1705 (1413 – 3190) | 0.1969 |
Absolute Lymphocyte Count (ALC) | 580 (350 – 820) | 885 (685 – 1510) | 0.0938 |
Absolute Monocyte Count (AMC) | 140 (60 – 200) | 135 (50 – 332.5) | 0.8706 |
Absolute Neutrophil Count (ANC) | 760 (330 – 900) | 505 (307.5 – 1565) | 0.9850 |
Trough ANC | 140 (30 – 310) | 125 (77.5 – 290) | 0.5465 |
G-CSF Therapy (Past or Current/None) (number) | 6/1 | 14/0 | 0.1588 |
Plerixafor Therapy (Past or Current/None) (number) | 4/3 | 13/1 | 0.0877 |
IVIG Therapy (Past or Current/None) (number) | 4/3 | 6/8 | 0.6594 |
Values given as median (interquartile range) unless otherwise indicated. Significant p-values are in bold.